Cargando…
Current frontline approaches in the management of hepatocellular carcinoma: the evolving role of immunotherapy
Hepatocellular carcinoma (HCC) is a major cause of cancer-associated mortality worldwide and is expected to rise. Patients with early-stage disease may have a good prognosis with a 5-year survival rate of greater than 70%. However, the majority of patients are diagnosed with late-stage disease with...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202741/ https://www.ncbi.nlm.nih.gov/pubmed/30377451 http://dx.doi.org/10.1177/1756284818808086 |